ZEB2 and systemic lupus erythematosus: To investigate how ZEB2 impacts pathogenic ABCs, we investigated the consequences of Zeb2 deficiency in B cells using two lupus mouse models (lupus induced by the TLR7 agonist imiquimod (IMQ) and bm12 cell transfer) as well as an acute LCMV infection model.